Home » Depomed’s ProQuin XR Achieves First Marketing Authorization in Europe
Depomed’s ProQuin XR Achieves First Marketing Authorization in Europe
Depomed, Inc. and Rottapharm/Madaus announced that the Marketing Authorization for ProQuin XR has been received from the Medical Products Agency in Sweden.
Fox Business
Fox Business
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May